Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled time : 12:30 save search
enGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development
Published: 2024-04-09 (Crawled : 12:30) - prnewswire.com
ENGN | $14.7 3.74% 3.61% 10K
|
n/a
|
| O: -4.12%
H: 4.93%
C: 2.34%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals Court Win
Published: 2024-04-02 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug patent schizophrenia
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
wegovy
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
fda drug approval hypertension
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to...
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
fda approval hypertension
J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline
Published: 2024-03-18 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
pipeline
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
Published: 2024-03-15 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
first breyanzi car-t leukemia therapy
Merck, J&J Add to 2024 M&A Upswing
Published: 2024-03-12 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
Biopharma Mergers and Acquisitions Continue to Trend Upward in 2024
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
acquisitions biopharma
J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
first psoriasis
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 1.08%
H: 3.77%
C: 1.97%
biotech year results
J&J Adds to 2024 M&A Upswing
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
Published: 2024-02-27 (Crawled : 12:30) - globenewswire.com
GCAN | $0.0005 16.67% 15K
|
|
| O: 0.0%
H: 0.0%
C: -14.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
neuropsychiatric preclinical therapy study
Royalty Pharma Reports Q4 and Full Year 2023 Results
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.26%
H: 3.99%
C: 1.21%
pharma year royalty results
Foundation Fighting Blindness to honor Stephen Rappoport of L'Amy America and Noah Katz of PSK Supermarkets at the 2024 Night for Sight Gala in New York
Published: 2024-02-15 (Crawled : 12:30) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
america
Kenvue Reports Full Year and Fourth Quarter 2023 Results
Published: 2024-02-08 (Crawled : 12:30) - biospace.com/
KVUE 4 | $19.58 0.72% 9.5M
|
n/a
|
| O: -3.27%
H: 0.98%
C: -2.62%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
year results
Legal-Bay Lawsuit Funding Expands Branch Dedicated to Medical Malpractice Cases
Published: 2024-01-31 (Crawled : 12:30) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.49%
H: 0.14%
C: -0.94%
medical funding
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
Published: 2023-12-15 (Crawled : 12:30) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
ACIU | $2.375 -0.21% -0.21% 320K
|
Health Technology
|
| O: -1.62%
H: 9.04%
C: 7.4%
disease active alzheimer’s immunotherapy trial
ACROBiosystems launches GM-grade DLL4 Protein to accelerate stem cell manufacturing
Published: 2023-11-16 (Crawled : 12:30) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.4%
H: 0.0%
C: 0.0%
cell protein
Activists Declare Victory After Pushing J&J, Danaher to Lower Price of Tuberculosis Care
Published: 2023-11-08 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 0.37%
H: 0.73%
C: -1.09%
care
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.